Here is what the clinical trials actually show
Thus, we revealed the essential healing commonality between the BPC 157, L-arginine, L-NAME and NO-system (10, 12)
Pierre-Louis: That said, the flip side, you know, these drugs are not a panacea, and we are finding some things that are maybe concerning
While some people respond to taking a very small dose called super responders others cannot tolerate moving up to the next higher standard dose and need something in between. This helps explain why one recent study among patients with diabetes found that microdosing helped them stick with their GLP-1s, reducing side effects without compromising efficacy
Swallow the tablet or extended-release tablet whole with a full glass of water
Sports Health 2025: Orthopedic review